Search

Displaying results 8271 - 8280 of 9117 in total
  1. Drug

    Simlukafusp alfa

    go.drugbank.com/drugs/DB16092
    Investigational

    RO6874281 is under investigation in clinical trial NCT03193190 (A Study of Multiple Immunotherapy-based Treatment Combinations in Participants With Metastatic Pancreatic Ductal Adenocarcinoma (Morpheus-pancreatic

  2. Drug

    APG-1387

    go.drugbank.com/drugs/DB16095
    Investigational

    APG-1387 is under investigation in clinical trial NCT04568265 (A Clinical Study of APG-1387 in Combination With Entecavir in Patients With Chronic Hepatitis B).

  3. Drug

    Batoclimab

    go.drugbank.com/drugs/DB16104
    Investigational

    Batoclimab is under investigation in clinical trial NCT04428255 (A Clinical Study on the Efficacy and Safety of HBM9161 in Patients With ITP).

  4. Drug

    Vorbipiprant

    go.drugbank.com/drugs/DB16111
    Investigational

    CR6086 is under investigation in clinical trial NCT03163966 (A Study of the EP4 Antagonist CR6086 in Combination With Methotrexate, in Dmard-naïve Patients With Early Rheumatoid Arthritis).

  5. Drug

    Cemdisiran

    go.drugbank.com/drugs/DB16121
    Investigational

    Cemdisiran is under investigation in clinical trial NCT03841448 (A Study of Cemdisiran in Adults With Immunoglobulin a Nephropathy (Igan)).

  6. Drug

    Dilpacimab

    go.drugbank.com/drugs/DB16140
    Investigational

    Dilpacimab is under investigation in clinical trial NCT03368859 (A Study of ABT-165 Plus FOLFIRI vs Bevacizumab Plus FOLFIRI in Subjects With Metastatic Colorectal Cancer Previously Treated With Fluoropyrimidine

  7. Drug

    Fonadelpar

    go.drugbank.com/drugs/DB16169
    Investigational

    Fonadelpar is under investigation in clinical trial NCT03527212 (A Study to Assess the Safety and Effectiveness of SJP-0035 for the Treatment of Patients With Dry Eye Disease).

  8. Drug

    CXD101

    go.drugbank.com/drugs/DB16182
    Investigational

    CXD101 is under investigation in clinical trial NCT03873025 (A Study of CXD101 in Combination With Pembrolizumab for Relapsed or Refractory Diffuse Large B-cell Lymphoma).

  9. Drug

    N-sulfoglucosamine sulfohydrolase recombinant

    go.drugbank.com/drugs/DB12722
    Investigational

    N-sulfoglucosamine sulfohydrolase recombinant is under investigation for the treatment of Mucopolysaccharidosis III and Sanfilippo Syndrome Type A (MPS IIIA).

  10. Drug

    Contezolid

    go.drugbank.com/drugs/DB12796
    Investigational

    MRX-I has been used in trials studying the treatment of Bacterial Infections.

    Categories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substrates